Literature DB >> 4876805

Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen.

H Závadová, L Kutinová, V Vonka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4876805     DOI： 10.1007/BF01275222

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  9 in total

1.  FLUORESCENT ANTIBODY STUDIES WITH NDV-INFECTED CELL SYSTEMS.

Authors:  I M REDA; R ROTT; W SCHAEFER
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

2.  PLAQUE TECHNIQUE WITH AN INFLUENZA A-2 VIRUS IN RUBBER STOPPERED BOTTLE CULTURES FROM MONKEY KIDNEY CELLS.

Authors:  V VONKA
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 1. Studies employing a low multiplicity of infection in beef embryo kidney cells.

Authors:  O A HOLTERMANN; W D HILLIS; M A MOFFAT
Journal:  Acta Pathol Microbiol Scand       Date:  1960

4.  The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 2. Studies employing a high multiplicity of infection in beef embryo kidney cells.

Authors:  M A MOFFAT; O A HOLTERMANN; W D HILLIS
Journal:  Acta Pathol Microbiol Scand       Date:  1960

5.  Antigenic analysis of influenza viruses by complement fixation. II. The production of antisera to strain-specific V antigens in guinea pigs.

Authors:  A FABIYI; F S LIEF; W HENLE
Journal:  J Immunol       Date:  1958-12       Impact factor: 5.422

6.  Antigenic analyses of influenza viruses by complement fixation. I. The production of antibodies to the soluble antigen in guinea pigs.

Authors:  F S LIEF; A FABIYI; W HENLE
Journal:  J Immunol       Date:  1958-01       Impact factor: 5.422

7.  Attempts to influence the incomplete reproductive cycle of influenza virus in HeLa cells by antibodies.

Authors:  H LOEFFLER; G HENLE; W HENLE
Journal:  J Immunol       Date:  1962-06       Impact factor: 5.422

8.  Physical and biological properties of influenza virus components obtained after ether treatment.

Authors:  F M DAVENPORT; R ROTT; W SCHAEFER
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

9.  Studies on influenza infection in ferrets by means of fluorescein-labelled antibody. II. The role of soluble antigen in nuclear fluorescence and cross-reactions.

Authors:  C LIU
Journal:  J Exp Med       Date:  1955-06-01       Impact factor: 14.307
  9 in total
  9 in total

1.  Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.

Authors:  H Závadová; V Vonka; E Adam; E Domorázková; F M Davenport
Journal:  Arch Gesamte Virusforsch       Date:  1972

2.  Infections with herpesviruses in a closed infants' community.

Authors:  J Holý; K Vanĕcek; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Influence of cis-dichlorodiammineplatinum (II) on growth of SV 40 virus in green monkey kidney cells.

Authors:  L Kutinová; V Vonka; H Závadová; J Drobník
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Morphological changes in BHK-21 cells infected with S-N (H2N1) influenza virus.

Authors:  E Anisimová; E Tucková; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  A Tween-ether preparation of Toxoplasma gondii antigen for the complement fixation test.

Authors:  J P Pokorný; Z Frühbauer; B Curík; M Zástĕra
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

6.  Immunological potency of a subunit influenza vaccine in adults.

Authors:  V Janout; M Uvizl
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

7.  Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens.

Authors:  L Kutinová; V Slichtová; V Vonka
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

8.  Herpesvirus group antibodies in children with Hodgkin's disease.

Authors:  J Holy; O Hrodek; J Srajer
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

9.  Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.

Authors:  L Kutinová; V Vonka
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.